• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚集作用在蛋白质淀粉样纤维形成过程中驱动“错误折叠”。

Aggregation drives "misfolding" in protein amyloid fiber formation.

作者信息

Xu Shaohua

机构信息

Biological Sciences Department, Florida Institute of Technology, Melbourne, FL 32901, USA.

出版信息

Amyloid. 2007 Jun;14(2):119-31. doi: 10.1080/13506120701260059.

DOI:10.1080/13506120701260059
PMID:17577685
Abstract

Protein amyloid fibers are often found to have a beta-pleated sheet structure regardless of their sequence, leading some to believe that it is the molecule's misfolding that leads to aggregation. In this article, an alternative model is introduced for the amyloid community to consider, that fiber formation is a surface-energy minimization process, starting with the generation of colloidal particles and their linear assembly, and ending with structural evolution of the aggregates into mature fibers. We propose that aggregation drives conformational change and that a conformational change is not essential to initiate the aggregation process.

摘要

蛋白质淀粉样纤维无论其序列如何,通常都具有β折叠片层结构,这使得一些人认为是分子的错误折叠导致了聚集。在本文中,为淀粉样蛋白领域引入了另一种模型供其考虑,即纤维形成是一个表面能最小化过程,始于胶体颗粒的产生及其线性组装,终于聚集体向成熟纤维的结构演化。我们提出聚集驱动构象变化,并且构象变化对于启动聚集过程并非必不可少。

相似文献

1
Aggregation drives "misfolding" in protein amyloid fiber formation.聚集作用在蛋白质淀粉样纤维形成过程中驱动“错误折叠”。
Amyloid. 2007 Jun;14(2):119-31. doi: 10.1080/13506120701260059.
2
Replica exchange molecular dynamics simulations of amyloid peptide aggregation.淀粉样肽聚集的复制交换分子动力学模拟
J Chem Phys. 2004 Dec 1;121(21):10748-56. doi: 10.1063/1.1809588.
3
Cross-beta-sheet structure in amyloid fiber formation.淀粉样纤维形成中的交叉β-折叠结构。
J Phys Chem B. 2009 Sep 17;113(37):12447-55. doi: 10.1021/jp903106x.
4
Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates.淀粉样纤维形成的早期动力学揭示了初始聚集体的构象重组。
J Mol Biol. 2007 Mar 2;366(4):1351-63. doi: 10.1016/j.jmb.2006.12.007. Epub 2006 Dec 15.
5
Self-folding and aggregation of amyloid nanofibrils.淀粉样原纤维的自折叠和聚集。
Nanoscale. 2011 Apr;3(4):1748-55. doi: 10.1039/c0nr00840k. Epub 2011 Feb 23.
6
Structure-specific effects of protein topology on cross-beta assembly: studies of insulin fibrillation.蛋白质拓扑结构对交叉β组装的结构特异性影响:胰岛素纤维化研究
Biochemistry. 2006 Aug 29;45(34):10278-93. doi: 10.1021/bi060879g.
7
Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.全长朊病毒蛋白通过不同途径聚集成淀粉样纤维和球形颗粒。
FEBS J. 2008 May;275(9):2021-31. doi: 10.1111/j.1742-4658.2008.06356.x. Epub 2008 Mar 18.
8
Dead-end street of protein folding: thermodynamic rationale of amyloid fibril formation.蛋白质折叠的死胡同:淀粉样纤维形成的热力学原理
J Am Chem Soc. 2007 Dec 5;129(48):14959-65. doi: 10.1021/ja0747122. Epub 2007 Nov 13.
9
A native to amyloidogenic transition regulated by a backbone trigger.由主链触发调节的淀粉样蛋白生成转变的天然状态。
Nat Struct Mol Biol. 2006 Mar;13(3):202-8. doi: 10.1038/nsmb1068. Epub 2006 Feb 19.
10
Design of model systems for amyloid formation: lessons for prediction and inhibition.淀粉样蛋白形成模型系统的设计:预测与抑制的经验教训
Curr Opin Struct Biol. 2005 Feb;15(1):57-63. doi: 10.1016/j.sbi.2005.01.004.

引用本文的文献

1
Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning.金丝桃素作为一种治疗阿尔茨海默病和 2 型糖尿病的潜在药物,以期进行药物重定位。
CNS Neurosci Ther. 2023 Nov;29(11):3307-3321. doi: 10.1111/cns.14260. Epub 2023 May 14.
2
Amyloidogenesis: What Do We Know So Far?淀粉样变性:目前我们了解多少?
Int J Mol Sci. 2022 Nov 12;23(22):13970. doi: 10.3390/ijms232213970.
3
Tumorigenic p53 mutants undergo common structural disruptions including conversion to α-sheet structure.致癌性 p53 突变体经历常见的结构破坏,包括转化为 α-螺旋结构。
Protein Sci. 2020 Sep;29(9):1983-1999. doi: 10.1002/pro.3921. Epub 2020 Aug 17.
4
Gels of Amyloid Fibers.淀粉样纤维凝胶。
Biomolecules. 2019 May 30;9(6):210. doi: 10.3390/biom9060210.
5
Peptides as Potential Therapeutics for Alzheimer's Disease.肽类作为治疗阿尔茨海默病的潜在药物。
Molecules. 2018 Jan 30;23(2):283. doi: 10.3390/molecules23020283.
6
Emerging links between type 2 diabetes and Alzheimer's disease.2 型糖尿病与阿尔茨海默病之间新出现的联系。
World J Diabetes. 2015 Jun 10;6(5):744-51. doi: 10.4239/wjd.v6.i5.744.
7
Gel formation in protein amyloid aggregation: a physical mechanism for cytotoxicity.蛋白质淀粉样聚集中的凝胶形成:细胞毒性的物理机制。
PLoS One. 2014 Apr 16;9(4):e94789. doi: 10.1371/journal.pone.0094789. eCollection 2014.
8
Cooperativity among short amyloid stretches in long amyloidogenic sequences.长淀粉样序列中短淀粉样伸展的协同作用。
PLoS One. 2012;7(6):e39369. doi: 10.1371/journal.pone.0039369. Epub 2012 Jun 22.
9
Imaging nanometer-sized α-synuclein aggregates by superresolution fluorescence localization microscopy.通过超分辨率荧光定位显微镜成像纳米级α-突触核蛋白聚集体。
Biophys J. 2012 Apr 4;102(7):1598-607. doi: 10.1016/j.bpj.2012.03.010. Epub 2012 Apr 3.
10
Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation.α-突触核蛋白聚集早期的超分子非淀粉样中间产物。
Biophys J. 2012 Mar 7;102(5):1127-36. doi: 10.1016/j.bpj.2012.01.051. Epub 2012 Mar 6.